Financial Contrast: Teleflex (NYSE:TFX) versus Advanced Biomedical Technologies (OTCMKTS:ABMT)

Teleflex (NYSE:TFX) and Advanced Biomedical Technologies (OTCMKTS:ABMT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, earnings, dividends and risk.

Insider and Institutional Ownership

95.6% of Teleflex shares are owned by institutional investors. 0.7% of Teleflex shares are owned by company insiders. Comparatively, 34.1% of Advanced Biomedical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Volatility and Risk

Teleflex has a beta of 0.82, indicating that its stock price is 18% less volatile than the S&P 500. Comparatively, Advanced Biomedical Technologies has a beta of 1.46, indicating that its stock price is 46% more volatile than the S&P 500.

Valuation and Earnings

This table compares Teleflex and Advanced Biomedical Technologies”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Teleflex	$2.13 billion	2.70	-$905.64 million	($22.80)	-5.70
Advanced Biomedical Technologies	N/A	N/A	N/A	N/A	N/A

Advanced Biomedical Technologies has lower revenue, but higher earnings than Teleflex.

Profitability

This table compares Teleflex and Advanced Biomedical Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Teleflex	-35.88%	13.29%	6.55%
Advanced Biomedical Technologies	N/A	N/A	N/A

Analyst Ratings

This is a summary of current ratings and target prices for Teleflex and Advanced Biomedical Technologies, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Teleflex	1	5	3	0	2.22
Advanced Biomedical Technologies	0	0	0	0	0.00

Teleflex currently has a consensus price target of $144.00, indicating a potential upside of 10.86%. Given Teleflex’s stronger consensus rating and higher possible upside, research analysts plainly believe Teleflex is more favorable than Advanced Biomedical Technologies.

Summary

Teleflex beats Advanced Biomedical Technologies on 7 of the 10 factors compared between the two stocks.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

About Advanced Biomedical Technologies

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.